Technology giants are competing to build Datacenters as the PCB Industry continues to thrive.

① Amazon's Cloud Computing division, Amazon Web Services (AWS), plans to invest at least 11 billion dollars in Georgia to expand its infrastructure and support various Cloud Computing and AI technologies. ② The investment team pointed out that driven by AI technologies and applications, Servers will be the fastest-growing application area in PCBs, with an expected CAGR of 11.6% to 14.2 billion dollars from 2023 to 2028.

cls.cn19:02 ET

[Data Analysis] Institutions have continuously increased their holdings in SGSG Science&Technology, and multiple Robot Concept stocks have been aggressively purchased by frontline speculators.

① The popular Internet Finance stock SGSG Science&Technology received over 90 million in buys from Institutions, and yesterday, this stock also saw purchases of 0.134 billion from Institutions. ② Top-tier funds bought multiple Robot Concept stocks, among which Shenzhen Sunwin Intelligent was purchased by two top-tier funds with a total exceeding 100 million.

cls.cnJan 8 04:54 ET

Investing over 0.4 billion, Qiming Venture Capital enters Zhengzhou Tiamaes Technology. Is the "shell buying craze" restarting?

① After this Trade is completed, the controlling Shareholder of Zhengzhou Tiamaes Technology will change to Qiming Fund, and the actual controller of the listed company will change to Kuang Ziping. The latter is the founding managing partner of Qiming Venture Capital. ② People from the Venture Capital Institutions indicate that Qiming Venture Capital's entry into Zhengzhou Tiamaes Technology this time may ultimately aim to realize investment exit by injecting its Assets into the listed company. ③ A wave of "shell buying" by Venture Capital Institutions occurred in the A-share market in 2019.

cls.cnJan 7 04:58 ET

Qingdao Haier Biomedical Co., Ltd.'s merger plan for "Blood King" has failed.

A specific plan recognized by all relevant parties could not be formed.

wallstreetcnJan 7 03:23 ET

Zhengzhou Tiamaes Technology's "change of ownership" plan has emerged: Trade sets "different pricing for the same shares" with well-known VC participating in the integration.

① The well-known VC Qiming Venture Capital founder Kuang Ziping is about to become the actual controller of Zhengzhou Tiamaes Technology; ② This Trade adopts differentiated pricing, and industry insiders indicate that differentiated pricing helps provide more negotiation space, which can facilitate the acquisition and achieve a fair Trade.

cls.cnJan 7 02:46 ET

Due to a lack of consensus among all parties, Qingdao Haier Biomedical Co., Ltd. has pressed the termination button on the merger with Shanghai RAAS Blood Products | Read the announcement quickly.

① The reason for terminating the reorganization is that the main shareholders of the trading parties and the merging parties failed to formulate a specific plan recognized by all relevant parties; ② Shanghai RAAS Blood Products and Qingdao Haier Biomedical Co., Ltd. will resume trading on January 7 and announce a share buyback simultaneously; ③ According to informed sources, the goal of Haier Group to expand its health sector will not change.

cls.cnJan 6 10:59 ET